Literature DB >> 23616272

Protease resistant protein cellular isoform (PrP(c)) as a biomarker: clues into the pathogenesis of HAND.

Bezawit Megra1, Eliseo Eugenin, Toni Roberts, Susan Morgello, Joan W Berman.   

Abstract

HIV infection and HIV neurocognitive impairment are major global health problems. The prevalence of HIV associated neurocognitive disorders (HAND) is increasing as people with HIV are living longer due to the success of antiretroviral therapies. Our laboratory identified the soluble form of (sPrP(c)), the cellular non-pathogenic isoform of the prion protein, as a biomarker of HAND. In this review we discuss the published data addressing PrP(c) biology in normal conditions and pathologies, as well as the mechanisms of sPrP(c) shedding and secretion. Lastly, we discuss our studies that demonstrated that sPrP(c) is a biomarker of neurocognitive impairment in the HIV infected population.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23616272      PMCID: PMC3797864          DOI: 10.1007/s11481-013-9458-4

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  82 in total

1.  Cellular and subcellular morphological localization of normal prion protein in rodent cerebellum.

Authors:  J Lainé; M E Marc; M S Sy; H Axelrad
Journal:  Eur J Neurosci       Date:  2001-07       Impact factor: 3.386

2.  Recombinant prion protein induces rapid polarization and development of synapses in embryonic rat hippocampal neurons in vitro.

Authors:  Jamil Kanaani; Stanley B Prusiner; Julia Diacovo; Steinunn Baekkeskov; Giuseppe Legname
Journal:  J Neurochem       Date:  2005-12       Impact factor: 5.372

3.  Junctional expression of the prion protein PrPC by brain endothelial cells: a role in trans-endothelial migration of human monocytes.

Authors:  Pedro Viegas; Nathalie Chaverot; Hervé Enslen; Nicolas Perrière; Pierre-Olivier Couraud; Sylvie Cazaubon
Journal:  J Cell Sci       Date:  2006-10-24       Impact factor: 5.285

4.  Shedding of PECAM-1 during HIV infection: a potential role for soluble PECAM-1 in the pathogenesis of NeuroAIDS.

Authors:  E A Eugenin; R Gamss; C Buckner; D Buono; R S Klein; E E Schoenbaum; T M Calderon; J W Berman
Journal:  J Leukoc Biol       Date:  2006-01-13       Impact factor: 4.962

5.  Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis.

Authors:  M C Zink; G D Coleman; J L Mankowski; R J Adams; P M Tarwater; K Fox; J E Clements
Journal:  J Infect Dis       Date:  2001-09-10       Impact factor: 5.226

6.  Expression of cellular prion protein in the frontal and occipital lobe in Alzheimer's disease, diffuse Lewy body disease, and in normal brain: an immunohistochemical study.

Authors:  Payam Rezaie; Charlie C Pontikis; Lance Hudson; Nigel J Cairns; Peter L Lantos
Journal:  J Histochem Cytochem       Date:  2005-08       Impact factor: 2.479

7.  Genomic structure of the human prion protein gene.

Authors:  C Puckett; P Concannon; C Casey; L Hood
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

8.  The cellular prion protein modulates phagocytosis and inflammatory response.

Authors:  Cecília J G de Almeida; Luciana B Chiarini; Juliane Pereira da Silva; Patrícia M R E Silva; Marco Aurélio Martins; Rafael Linden
Journal:  J Leukoc Biol       Date:  2004-11-11       Impact factor: 4.962

9.  HIV-tat induces formation of an LRP-PSD-95- NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytes.

Authors:  Eliseo A Eugenin; Jessie E King; Avindra Nath; Tina M Calderon; R Suzanne Zukin; Michael V L Bennett; Joan W Berman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-21       Impact factor: 11.205

10.  Lipid rafts and clathrin cooperate in the internalization of PrP in epithelial FRT cells.

Authors:  Daniela Sarnataro; Anna Caputo; Philippe Casanova; Claudia Puri; Simona Paladino; Simona S Tivodar; Vincenza Campana; Carlo Tacchetti; Chiara Zurzolo
Journal:  PLoS One       Date:  2009-06-08       Impact factor: 3.240

View more
  7 in total

Review 1.  Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disorders.

Authors:  Dionna W Williams; Mike Veenstra; Peter J Gaskill; Susan Morgello; Tina M Calderon; Joan W Berman
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

Review 2.  HIV/neuroAIDS biomarkers.

Authors:  Pejman Rahimian; Johnny J He
Journal:  Prog Neurobiol       Date:  2016-04-12       Impact factor: 11.685

3.  Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders.

Authors:  Jacqueline Rosenthal; William Tyor
Journal:  J Neurovirol       Date:  2019-03-13       Impact factor: 2.643

Review 4.  Anchorless risk or released benefit? An updated view on the ADAM10-mediated shedding of the prion protein.

Authors:  Behnam Mohammadi; Feizhi Song; Andreu Matamoros-Angles; Mohsin Shafiq; Markus Damme; Berta Puig; Markus Glatzel; Hermann Clemens Altmeppen
Journal:  Cell Tissue Res       Date:  2022-01-27       Impact factor: 5.249

5.  Changes in PINCH levels in the CSF of HIV+ individuals correlate with hpTau and CD4 count.

Authors:  Radhika Adiga; Ahmet Y Ozdemir; Alexandra Carides; Melissa Wasilewski; William Yen; Pallavi Chitturi; Ronald Ellis; Dianne Langford
Journal:  J Neurovirol       Date:  2014-05-10       Impact factor: 2.643

6.  Biomarkers for NeuroAIDS: recent progress in the field.

Authors:  Howard S Fox
Journal:  J Neuroimmune Pharmacol       Date:  2013-11-29       Impact factor: 4.147

7.  Plasma soluble prion protein, a potential biomarker for sport-related concussions: a pilot study.

Authors:  Nam Pham; Hungbo Akonasu; Rhonda Shishkin; Changiz Taghibiglou
Journal:  PLoS One       Date:  2015-02-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.